Literature DB >> 8671400

Ovulation induction combined with intrauterine insemination in women 40 years of age and older: is it worthwhile?

G Corsan1, A Trias, S Trout, E Kemmann.   

Abstract

The use of ovulation induction combined with intrauterine insemination (IUI) as a treatment for subfertility in women with patent Fallopian tubes has increased in recent years. Little is known regarding the efficacy of this treatment in women aged >/=40 years. We reviewed our data in our ovulation induction with IUI programme for 168 consecutive patients aged >/=40 years undergoing a total of 469 cycles of treatment. Either sequential clomiphene citrate and human menopausal gonadotrophins or daily gonadotrophins were utilized along with timed IUI insemination. In 402 completed cycles, 28 clinical pregnancies occurred. The pregnancy loss rate was 34.4%. The overall ongoing/viable pregnancy rates per initiated and completed cycles were 4.47 and 5.22% respectively. No viable pregnancies occurred in 136 cycles in women aged >/=43 years. The ongoing/variable cycle fecundity rates for women aged 40, 41, and 42 years were 9.6, 5.2, and 2.4% per cycle respectively. When utilized in women aged >=40 years, ovulation induction with IUI is most likely to result in successful pregnancy in women 40-42 years of age. Women >/=43 years should consider other alternatives such as adoption or egg donation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8671400     DOI: 10.1093/oxfordjournals.humrep.a019306

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  9 in total

1.  Superovulation and intrauterine insemination in cases of treated mild pelvic disease.

Authors:  M Singh; J Goldberg; T Falcone; D Nelson; E Pasqualotto; M Attaran; A Agarwal
Journal:  J Assist Reprod Genet       Date:  2001-01       Impact factor: 3.412

2.  Intrauterine insemination with husband semen: an evaluation of pregnancy rate and factors affecting outcome.

Authors:  Shahrzad Zadehmodarres; Belgheis Oladi; Shahrbanoo Saeedi; Fatemeh Jahed; Haleh Ashraf
Journal:  J Assist Reprod Genet       Date:  2008-11-22       Impact factor: 3.412

3.  Fertility treatment in the forty and older woman.

Authors:  A Auyeung; M E Klein; V S Ratts; R R Odem; D B Williams
Journal:  J Assist Reprod Genet       Date:  2001-12       Impact factor: 3.412

Review 4.  Predicting suitable timing for artificial reproductive technology treatment in aged infertile women.

Authors:  Nana Akino; Wataru Isono; Osamu Wada-Hiraike
Journal:  Reprod Med Biol       Date:  2016-03-29

5.  Effect of clinical and semen characteristics on efficacy of ovulatory stimulation in patients undergoing intrauterine insemination.

Authors:  B N Hendin; T Falcone; J Hallak; J Goldberg; A J Thomas; D R Nelson; A Agarwal
Journal:  J Assist Reprod Genet       Date:  2000-04       Impact factor: 3.412

Review 6.  Ovulation induction and intrauterine insemination in women of advanced reproductive age: a systematic review of the literature.

Authors:  Carleigh B Nesbit; Misty Blanchette-Porter; Navid Esfandiari
Journal:  J Assist Reprod Genet       Date:  2022-06-22       Impact factor: 3.357

Review 7.  What is the best treatment option for infertile women aged 40 and over?

Authors:  Sarah Armstrong; Valentine Akande
Journal:  J Assist Reprod Genet       Date:  2013-03-29       Impact factor: 3.412

8.  Evaluation of pregnancy rates after intrauterine insemination according to indication, age, and sperm parameters.

Authors:  L A van der Westerlaken; N Naaktgeboren; F M Helmerhorst
Journal:  J Assist Reprod Genet       Date:  1998-07       Impact factor: 3.412

9.  Age, body mass index, and number of previous trials: are they prognosticators of intra-uterine-insemination for infertility treatment?

Authors:  Ahmed M Isa; Basim Abu-Rafea; Saleh A Alasiri; Saleh Binsaleh; Kareema H Ismail; George A Vilos
Journal:  Int J Fertil Steril       Date:  2014-11-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.